Cited by 373Pain Mechanisms and TreatmentsPeripheral Neuropathies and DisordersAldose Reductase and Taurine

Diabetic neuropathy

Vinik, Aaron I., Nevoret, Marie-Laure, Casellini, Carolina, Parson, Henri·2013·Endocrinology and Metabolism Clinics of North America

Abstract

Diabetic neuropathy (DN) is the most common and troublesome complication of diabetes mellitus, leading to the greatest morbidity and mortality and resulting in a huge economic burden for diabetes care. The clinical assessment of diabetic peripheral neuropathy and its treatment options are multifactorial. Patients with DN should be screened for autonomic neuropathy, as there is a high degree of coexistence of the two complications. A review of the clinical assessment and treatment algorithms for diabetic neuropathy, painful neuropathy, and autonomic dysfunction is provided.

Integrity signals

Registry

Crossref · 10.1016/j.ecl.2013.06.001

Cites

180 of 180 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The true prevalence of diabetic neuropathy is unclear but it varies from 10 to 90% in diabetics, according to the different standards and approaches used to define diabetic neuropathy.

    “The true prevalence is unclear but it varies from 10 to 90% in diabetics, according to the different standards and approaches used to define diabetic neuropathy (107).”
  • Neuropathy is associated with a 1.7-fold increase in the risk of amputation, and even higher when coupled with other problems.

    “It has been reported that neuropathy is associated with a 1.7-fold increase in the risk of amputation, and even higher when coupled with other problems (107).”

Cites

Flagged first, then by citations

1 of the 181 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Vinik, A. I., Nevoret, M.-L., Casellini, C., & Parson, H.
Affiliations
Eastern Virginia Medical School (US)
Corresponding author
Vinik, Aaron I.
Venue
Endocrinology and Metabolism Clinics of North America
Publisher
Elsevier BV
Published
2013-12
Volume
42
Issue
4
Pages
747-787
ISSN
0889-8529 (ISSN-L)
OpenAlex
W4210977503
Cited by
366
References
181
Citations by year
2026: 30 · 2025: 36 · 2024: 42 · 2023: 38 · 2022: 40 · 2021: 36 · 2020: 41 · 2019: 27 · 2018: 12 · 2017: 16 · 2016: 17 · 2015: 15 · 2014: 16
FWCI
1.76
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrinology and Metabolism Clinics of North America (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Neurology › Peripheral Neuropathies and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
Keywords
diabetic neuropathy, diabetic peripheral neuropathy, autonomic neuropathy, diabetic neuropathic pain, autonomic dysfunction, diabetes complications, neuropathy screening, clinical evaluation
MeSH terms
Autonomic Nervous System Diseases, Cardiovascular Diseases, Diabetic Neuropathies, Humans, Hyperglycemia, Neuralgia, Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review